张志凌 - Collaborative Innovation Center for Cancer Medicine Guangzhou, Sun Yat-sen University Cancer Center

基本信息

浏览量：85

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 132 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Trimethylamine-N-oxide (TMAO) and Predicted Risk of Cardiovascular Events after Partial Nephrectomy

Xiangpeng Zou,Longbin Xiong,Zhixing Guo,Yuchen Li,Kang Ning,Xiaohua Liu,Ye Xie,Yulu Peng, Yixuan Liu,Xinyang Cai,Boxin Zhao,Fangjian Zhou,Chunping Yu,Xia Zheng,Steven C. Campbell,Zhiling Zhang

ASIAN JOURNAL OF SURGERYno. 1 (2024): 281-288

引用0浏览0WOS引用

Re: Impact of Acute Kidney Injury and Its Duration on Long-term Renal Function after Partial Nephrectomy

Steven C. Campbell,Yun-Lin Ye,Zhiling Zhang,Joseph Zabell

Journal of Modern Urology（2024）

引用66浏览0WOS引用

Real-world Outcomes among Patients with Advanced/metastatic Renal Cell Carcinoma (mrcc) Treated with Tyrosine Kinase Inhibitors (tkls) Monotherapy or TKI-IO Combination Therapy

Pei Dong,Tingxuan Huang,Yulu Peng,Wensu Wei,Lijuan Jiang, Xi Zhong,Zhiling Zhang,Hui Han,Fangjian Zhou

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Chinese Quality Control Indices for Standardized Diagnosis and Treatment of Renal Cancer (2022 Edition)

Lin Yao,Yicong Du,Wen Dong,Xianshu Gao,Jun Guo,Jianxing Qiu,Qiang Wei,Shikai Wu,Dingwei Ye,Wei Yu,Hao Zeng,Qian Zhang,Yong Zhang,Zhiling Zhang,Fangjian Zhou,Wenjing Yang,Hui Wang,Xu Zhang,Zhisong He

JOURNAL OF THE NATIONAL CANCER CENTERno. 1 (2024): 6-13

引用0浏览0WOS引用

Safety and Efficacy of Second-Line TKI Plus Anti-PD1 in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World Study

Tingxuan Huang,Jun Wang,Ruiqi Liu,Wensu Wei,Yang Liu,Zhiling Zhang,Shengjie Guo,Hui Han,Fangjian Zhou,Liru He,Pei Dong

CLINICAL GENITOURINARY CANCERno. 2 (2024)

引用0浏览0WOS引用

Human Papillomavirus Infection Affects Treatment Outcomes and the Immune Microenvironment in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Programmed Cell Death Protein 1 Inhibitor-Based Combination Therapy

Lichao Wei,Zaishang Li,Shengjie Guo,Huali Ma,Yanxia Shi,Xin An,Kangbo Huang,Longbin Xiong,Ting Xue,Zhiling Zhang,Kai Yao,Junhang Luo,Hui Han

CANCERno. 9 (2024): 1650-1662

引用0浏览0WOS引用

Longitudinal Changes in Renal Parenchymal Volume and Function Status after Partial Nephrectomy: a Retrospective Cohort Study

Longbin Xiong,Xiangpeng Zou, Xin Luo,Shaohan Yin,Yixin Huang,Kang Ning,Dongxiang Wen,Zhaohui Zhou,Jun Wang,Zhen Li,Jiawei Chen,Jibin Li, Wei Peng,Shengjie Guo,Pei Dong,Fangjian Zhou,Hui Han,Yulu Peng,Chunping Yu,Zhiling Zhang

INTERNATIONAL JOURNAL OF SURGERYno. 2 (2024): 984-991

引用0浏览0WOS引用

An Exploratory Prospective Clinical Study on Efficacy and Safety of Anlotinib Combined with Sintilimab As First-Line Treatment in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma

Pei Dong,Wensu Wei,Lijuan Jiang,Zhiling Zhang, Deling Wang, Yulu Peng, Tingxuan Huang, Xi Zhong,Shengjie Guo,Hui Han,Xiuyu Cai,Fangjian Zhou

European Urology (2023): S753-S753

引用0浏览0引用

Supplementary data from Nkx2.8 Inhibits Epithelial–Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of <i>Twist1</i>

Chunping Yu,Zhuowei Liu,Qiuhong Chen,Yonghong Li,Lijuan Jiang,Zhiling Zhang,Fangjian Zhou

crossref（2023）

引用0浏览0引用

Figure S5 from Nkx2.8 Inhibits Epithelial–Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of <i>Twist1</i>

Chunping Yu,Zhuowei Liu,Qiuhong Chen,Yonghong Li,Lijuan Jiang,Zhiling Zhang,Fangjian Zhou

crossref（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Zhiling Zhang(张志凌)

论文共 132 篇作者统计合作学者相似作者